Cancer Immunotherapy in Understudied Populations

Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma
Fabian Ullrich, Paul J Bröckelmann, Amin T Turki, Abdullah M Khan, Elena-Diana Chiru, Marcus Vetter, Bastian von Tresckow, Rainer Wirth, Raul Cordoba, Valentín Ortiz-Maldonado, Tamas Fülöp, Nina Rosa Neuendorff

Journal for ImmunoTherapy of Cancer Dec 2024, 12 (12) e009462; DOI: 10.1136/jitc-2024-009462
Minority report on cancer immunotherapy: focus on elderly and other understudied populations
Kavita Dhodapkar, Johanneke Portielje

Journal for ImmunoTherapy of Cancer Oct 2024, 12 (10) e010560; DOI: 10.1136/jitc-2024-010560
Impact of race, ethnicity, and social determinants on outcomes following immune checkpoint therapy
Rahul K Nayak, Meili Aiello, Laneisha Marielis Maldonado, Tarralyn Y Clark, Zachary S Buchwald, Andres Chang

Journal for ImmunoTherapy of Cancer Oct 2024, 12 (10) e010116; DOI: 10.1136/jitc-2024-010116
Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018–2022
Colm Mac Eochagain, Robert Power, Christine Sam, Nicolas M Gonzalez-Senac, Darren Walsh, Mukul Roy, Nicolò Matteo Luca Battisti

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e009258; DOI: 10.1136/jitc-2024-009258

Main menu